Cutler Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-400
Closed -$2K 5546
2022
Q3
$2K Sell
400
-29,500
-99% -$8.49M ﹤0.01% 4326
2022
Q2
$2.43M Sell
29,900
-18,900
-39% -$5.06M 0.33% 130
2022
Q1
$2.25M Buy
48,800
+25,300
+108% +$6M 0.21% 190
2021
Q4
$1.06M Buy
+23,500
New +$4.57M 0.07% 438
2021
Q2
Sell
-1,500
Closed -$11K 6759
2021
Q1
$11K Buy
1,500
+400
+36% +$87.9K ﹤0.01% 3751
2020
Q4
$31K Hold
1,100
﹤0.01% 2346
2020
Q3
$74K Hold
1,100
0.01% 1518
2020
Q2
$98K Hold
1,100
0.01% 1324
2020
Q1
$54K Hold
1,100
0.01% 1681
2019
Q4
$41K Hold
1,100
﹤0.01% 1763
2019
Q3
$16K Buy
1,100
+100
+10% +$17.7K ﹤0.01% 2345
2019
Q2
$21K Sell
1,000
-6,800
-87% -$1.19M ﹤0.01% 2183
2019
Q1
$4K Sell
7,800
-6,300
-45% -$1.16M ﹤0.01% 3086
2018
Q4
$82K Sell
14,100
-800
-5% -$139K 0.01% 1164
2018
Q3
$291K Sell
14,900
-500
-3% -$89K 0.03% 677
2018
Q2
$235K Sell
15,400
-13,200
-46% -$2.05M 0.02% 716
2018
Q1
$349K Sell
28,600
-20,100
-41% -$3.28M 0.04% 549
2017
Q4
$542K Sell
48,700
-39,700
-45% -$5.88M 0.03% 520
2017
Q3
$1.32M Buy
88,400
+300
+0.3% +$45.2K 0.06% 279
2017
Q2
$1.07M Sell
88,100
-47,800
-35% -$5.75M 0.05% 395
2017
Q1
$1.87M Buy
135,900
+35,500
+35% +$3.13M 0.1% 223
2016
Q4
$252K Buy
100,400
+19,800
+25% +$1.61M 0.01% 1130
2016
Q3
$204K Buy
80,600
+36,300
+82% +$3.43M 0.01% 1191
2016
Q2
$180K Sell
44,300
-8,300
-16% -$717K 0.01% 1190
2016
Q1
$148K Sell
52,600
-5,200
-9% -$470K 0.01% 1239
2015
Q4
$714K Buy
+57,800
New +$6.98M 0.06% 463

Other funds holding VRTX